Red blood cell enzyme disorders: An overview

Pediatric Annals

Volumn 37, Issue 5, 2008, Pages 303-310

  Tavazzi, Dario ^a   Taher, Ali ^b   Cappellini, Maria Domenica ^a,c  

^a UNIVERSITY OF MILAN   (Italy)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c Fondazione IRCCS Ca   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE ENZYME; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; IRON CHELATING AGENT; PYRUVATE KINASE;

ANEMIA; BONE MARROW TRANSPLANTATION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; ENZYME DEFECT; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYTIC ANEMIA; HUMAN; MALARIA; PYRUVATE KINASE DEFICIENCY; REVIEW;

EID: 45349098379     PISSN: 00904481     EISSN: None     Source Type: Journal    
DOI: 10.3928/00904481-20080501-08     Document Type: Review

References (40)

1. Valentine WN, Tanaka KR, Paglia DE. Hemolytic anemias and erythrocyte enzymopathies. Ann Intern Med. 1985;103(2):245-57.
2. Jacobasch G.Biochemical and genetic basis of red cell enzyme deficiencies. Baillieres Best Pract Res Clin Haematol. 2000;13(1):1-20.
3. Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371(9606):64-74.
4. Tanaka KR, Paglia DE. Pyruvate kinase and other enzymopathies of the erythrocyte. In: Scriver CR, BeaudetAL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease. New York: McGraw-Hill; 1990:3485-3511.
5. Dacie J. Pyruvate-kinase deficiency. In: Dacie J, ed. The Hemolytic Anemias. 3rd ed. New York: Churchill Livingstone; 1985:284-320.
6. Lestas AN, Bellingham AJ.A logical approach to the investigation of red cell enzymopathies. Blood Rev. 1990;4(3):148-57.
7. Beutler E. Red Cell Metabolism: a Manual of Biochemical Methods, 3rd ed. New York: Grune and Statton; 1984:3-14.
8. WHO Working Group. Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ. 1989;67(6):601-611.
9. Luzzatto L, Metha A, Vulliamy T. Glucose 6-phosphate dehydrogenase deficiency. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. Columbus: McGraw-Hill; 2001:4517-4553.
10. Battistuzzi G, D'Urso M, Toniolo D, Persico GM, Luzzatto L. Tissue-specific levels of human glucose-6-phosphate dehydrogenase correlate with methylation of specific sites at the 3′ end of the gene. Prot Natl Acad Sci U S A. 1985;82(5):1465-1469.
11. Gaetani GD, Parker JC, Kirkman HN. Intracellular restraint: a new basis for the limitation in response to oxidative stress in human erythrocytes containing low-activity variants of glucose-6-phosphate dehydrogenase. Proc Natl Acad Sci U S A. 1974;71(9):3584-3587.
12. Bulliamy T, Luzzatto L, Hirono A, Beutler E. Hematologically important mutations: glucose-6-phosphate dehydrogenase. Blood Cells Mol Dis. 1997;23(2):302-313.
13. Mehta A, Mason PJ, Vulliamy TJ. Glucose-6-phosphate dehydrogenase deficiency. Baillieres Best Pract Res Clin Haematol. 2000;13(1):21-38.
14. Fiorelli G, Martinez di Montemuros F, Cappellini MD. Chronic non-spherocytic haemolytic disorders associated with glucose-6-phosphate dehydrogenase variants. Baillieres Best Pract Res Clin Haematol. 2000;13(1):39-55.
15. Town M, Bautista JM, Mason PJ, Luzzatto L.Both mutations in G6PD A- are necessary to produce the G6PD deficient phenotype. Hum Mol Genet. 1992;1(3):171-174.
16. Hirono A, Kawate K, Honda A, Fujii H, Miwa S.A single mutation 202G>A in the human glucose-6-phosphate dehydrogenase gene (G6PD) can cause acute hemolysis by itself. Blood. 200215;99(4):1498.
17. Ruwende C, Hill A. Glucose-6-phosphate dehydrogenase deficiency and malaria. J Mol Med. 1998 Jul;76(8):581-8.
18. Beutler E. G6PD: population genetics and clinical manifestations. Blood Rev. 1996;10(1):45-52.
19. Bienzle U, Ayeni O, Lucas AO, Luzzatto L. Glucose-6-phosphate dehydrogenase and malaria. Greater resistance of females heterozygous for enzyme deficiency and of males with non-deficient variant. Lancet. 1972;1(7742):107-110.
20. Mason PJ. New insights into G6PD deficiency. Br J Haematol. 1996;94(4):585-591.
21. Martinez di Montemuros F, Dotti C, Tavazzi D, Fiorelli G, Cappellini MD. Molecular heterogeneity of glucose-6-phosphate dehydroge-nase (G6PD) variants in Italy. Haematologica. 1997;82(4):440-5.
22. Kaplan M, Rubaltelli FF, Hammerman C, Vilei MT, Leiter C, Abramov A, Muraca M. Conjugated bilirubin in neonates with glucose-6-phosphate dehydrogenase deficiency. J Pediatr. 1996;128(5 Pt 1):695-697.
23. Dern RJ, Beutler E, Alving AS. The hemolytic effect of primaquine. II. The natural course of the hemolytic anemia and the mechanism of its self-limited character. J Lab Clin Med. 1954;44(2):171-176.
24. Edwards CQ. Anemia and the liver. Hepatobiliary manifestations of anemia. Clin Liver Dis. 2002;6(4):891-907, viii.
25. Cappellini MD, Martinez di Montemuros F, Sampietro M, Tavazzi D, Fiorelli G. The interaction between Gilbert's syndrome and G6PD deficiency influences bilirubin levels. Br J Haematol. 1999;104(4):928-929.
26. Newman TB, Maisels MJ. Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. Pediatrics. 1992;89(5Pt 1):809-818.
27. Hafez M, Amar ES, Zedan M, et al. Improved erythrocyte survival with combined vitamin E and selenium therapy in children with glucose-6-phosphate dehydrogenase deficiency and mild chronic hemolysis. J Pediatr. 1986;108(4):558-561.
28. Beutler E, Kuhl W, Fox M, Tabsh K, Crandall BF. Prenatal diagnosis of glucose-6-phosphate-dehydrogenase deficiency. Acta Haematol. 1992;87(1-2):103-104.
29. Kayne FJ. Pyruvate kinase. In Boyer PD, ed. Enzymes. 3rd ed. New York: Academic Press; 1973:353-382.
30. Valentine WN, Tanaka KR, Miwa S. A specific erythrocyte glycolytic enzyme defect (pyruvate kinase) in three subjects with congenital non-spherocytic hemolytic anemia. Trans Assoc Am Physicians. 1961;74:100-110.
31. Kanno H, Fujii H, Miwa S.Structural analysis of human pyruvate kinase L-gene and identification of the promoter activity in erythroid cells. Biochem Biophys Res Commun. 1992;188(2):516-523.
32. Tani K, Fujii H, Nagata S, Miwa S. Human liver type pyruvate kinase: complete amino acid sequence and the expression in mammalian cells. Proc Natl Acad Sci U S A. 1988;85(6):1792-5.
33. Baronciani L, Bianchi P, Zanella A. Hematologically important mutations: red cell pyruvate kinase (2nd update). Blood Cells Mol Dis. 1998;24(3):273-279.
34. Zanella A, Fermo E, Bianchi P, Valentini G. Red cell pyruvate kinase deficiency: molecular and clinical aspects. Br J Haematol. 2005;130(1):11-25.
35. Mentzer WC, Glader BE. Disorders of erythrocyte metabolism. In: Mentzer WC, Wagner GM, eds. The Hereditary Hemolytic Anemias. New York: Churchill Livingstone; 1989:267-318.
36. Nakashima K, Miwa S, Fujii H, et al. Characterization of pyruvate kinase from the liver of a patient with aberrant erythrocyte pyruvate kinase, PK Nagasaki. J Lab Clin Med. 1977;90(6):1012-1020.
37. Zanella A, Berzuini A, Colombo MB, et al. Iron status in red cell pyruvate kinase deficiency: study of Italian cases. Br J Haematol. 1993;83(3):485-490.
38. Zanella A, Bianchi P, Iurlo A, et al. Iron status and HFE genotype in erythrocyte pyruvate kinase deficiency: study of Italian cases. Blood Cells Mol Dis. 2001;27(3):653-661.
39. Tanphaichitr VS, Suvatte V, Issaragrisil S, et al. Successful bone marrow transplantation in a child with red blood cell pyruvate kinase deficiency. Bone Marrow Transplant. 2000;26(6):689-690.
40. Tani K, Yoshikubo T, Ikebuchi K, et al.Retrovirus-mediated gene transfer of human pyruvate kinase (PK) cDNA into murine hematopoietic cells: implications for gene therapy of human PK deficiency. Blood. 1994;83(8):2305-2310.